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Abstract
The H-2b-restricted CD8 T-cell response against lymphocytic choriomeningitis virus is directed against at least 10 dominant and
subdominant epitopes, including two newly identified epitopes in the nucleoprotein. We have used this set of epitopes to characterize the
plasticity of the hierarchy under different experimental circumstances, i.e., loss of MHC class I molecules, loss of specific epitopes (CTL
escape), and prolonged antigenic stimulation (chronic infection). We found that loss of epitope-specific responses was almost inevitably
associated with compensatory responses against other, subdominant, epitopes. Multiple epitope loss was required to change the hierarchy.
Persistent viral infection was associated with a loss of not only the dominant response against the NP396 epitope, but also a loss of
subdominant responses against nucleoprotein epitopes. In contrast, responses against glycoprotein epitopes, dominant and subdominant,
survived under chronic infection conditions, and even dominated the response (GP118). Our results suggest that the fate of each specific
T-cell response during chronic infection is in part determined by the origin of the cognate epitopes, i.e, the proteins from which they are
processed, or, more specifically, nucleoprotein versus glycoprotein. A model in which recruitment time plays a role in the longevity of
antiviral T-cell responses during persistent infection is discussed.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
The specificity of antimicrobial CD8 T-cell responses is
highly focused against a relatively small number of epitopes
(Gallimore et al., 1998b; Yewdell and Bennink, 1999).
Among these immunogenic peptides, a few dominant
epitopes elicit the strongest responses. Other immunogenic
peptides induce weaker responses and are referred to as
subdominant. There are several factors influencing the dom-
inance or subdominance of a given peptide, including MHC
class I binding affinity, stability of the MHC–peptide com-
plex, antigen processing and presentation, and the repertoire
of T-cell receptors (Chen et al., 2000; Gallimore et al.,
1998b; Yewdell and Bennink, 1999). Together, these fac-
tors shape the epitope hierarchy. Despite these rules for
immunodominance, epitope hierarchies have turned out to
be highly dynamic. The concept of immunodomination im-
plies that immunodominance and subdominance are contex-
tual issues; i.e, the place of a given epitope in the hierarchy
is dependent on other epitopes (Yewdell and Bennink,
1999). For instance, HLA-A2 restricted epitopes from HIV
that had been defined as immunodominant were subdomi-
nant in other HLA-A2-positive individuals (Betts et al.,
2000). Similar results have been found in hepatitis C virus-
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infected subjects (Lauer et al., 2002). Thus, hierarchies
change as a result of the different sets of MHC class I
molecules in each individual haplotype. Also, the epitope
hierarchy will change when epitopes are lost due to the
occurrence of T-cell epitope escape mutants (Nowak et al.,
1995; Mothe et al., 2002; Goulder et al., 1997). Finally,
epitope hierarchies may change during chronic viral infec-
tion (Gruener et al., 2001; Zajac et al., 1998; Fuller and
Zajac, 2003; Wherry et al., 2003; Goulder et al., 2001;
Stevenson et al., 1999; Bergmann et al., 1999). The pro-
longed antigenic stimulation during chronic infection has
been associated with epitope-specific unresponsiveness or
deletion of T cells. For instance, in mice that are chronically
infected with lymphocytic choriomeningitis virus (LCMV),
antiviral CD8 T cells recognizing the dominant epitope
from the nucleoprotein (NP396) are deleted, whereas T cells
specific for the codominant glycoprotein epitope GP33 un-
dergo functional inactivation (Zajac et al., 1998; Fuller and
Zajac, 2003; Wherry et al., 2003). As a consequence, the
hierarchy may change (Zajac et al., 1998; Fuller and Zajac,
2003; Zhou et al., 2002; Wherry et al., 2003; van der Most
et al., 1996). In fact, LCMV infection in mice represents a
unique model to study the dynamics of immunodomination
because a large number of CD8 T-cell epitopes have been
defined (Gallimore et al., 1998c; Hudrisier et al., 1997;
Oldstone et al., 1995; van der Most et al., 1998).
In the present study, we have altered the number of
epitopes “seen” during LCMV infection and we have ana-
lyzed the impact of these changes on the hierarchy. We first
analyzed the epitope hierarchies in H-2Db and H-2Kb
knockout mice (Pe´rarnau et al., 1999), thereby mimicking
the effect of different MHC class I constellations. Second,
we have used an LCMV variant virus in which the dominant
GP33 epitope is lost as the result of a mutation (Puglielli et
al., 2001), modeling the effect of CTL escape. Finally, we
have compared antiviral responses during acute and chronic
LCMV infection, exploiting the loss of the dominant CD8
T-cell response against NP396 during chronic infection
(Zajac et al., 1998). Combined, these three approaches al-
lowed us to manipulate the number of epitopes seen during
viral infection. Our results make it clear that the epitope
hierarchy undergoes profound changes when multiple
epitopes are lost. In the most dramatic situation, i.e., in the
H-2Db knockout mice chronically infected with the LCMV
escape variant, only three epitopes are recognized, and one
subdominant epitope, GP118, dominates the entire antiviral
response. After persistent viral infection, we found that the
fate of CD8 T cells recognizing glycoprotein (GP) epitopes
differed from those T cells specific for nucleoprotein
epitopes (NP): in general, (subdominant) GP-specific re-
sponses became dominant, whereas all NP-specific re-
sponses disappeared. Our data suggest that there exists a
link between the origin of the epitopes (i.e., NP versus GP)
and the eventual fate and longevity of the cognate CD8 T
cells.
Results
Epitope hierarchy during the effector and memory phases
in acute infection
Infection of C57BL/6 mice (H-2b) with LCMV induces a
potent antiviral CD8 T-cell response (Murali-Krishna et al.,
1998). To make sure that we would analyze the entire breadth
of the response, we used a library of overlapping 15-mer
peptides spanning GP and NP to find potential new epitopes.
Splenocytes from LCMV-infected mice were stimulated with
individual 15-mer peptides and responses were visualized by
intracellular cytokine staining (data not shown). We identified
two novel epitopes in the nucleoprotein, NP235 and NP163,
and confirmed our previous finding (van der Most et al., 1998)
of a new epitope in the glycoprotein (GP118) (Table 1). With
the exception of GP117 (Gallimore et al., 1998c), we have
included the entire range of viral epitopes in our experiments,
including the newly identified epitopes. The responses against
this set of epitopes (Table 1), during and after acute infection
with the Armstrong strain of LCMV, are shown in Fig. 1.
Clearly, NP396 and GP33 are the two dominant epitopes, and,
consistent with previous data (Murali-Krishna et al., 1998), the
Fig. 1. Antiviral CD8 T-cell responses during acute infection with LCMV
ARM at Day 8 (upper panel) and Day 68 postinfection (lower panel).
Splenocytes were stimulated with the indicated peptides and CD8/
IFN- T cells are shown (results from three individual mice). Note that
stimulation with GP33 reveals both GP33/Db and GP34/Kb responses.
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epitope hierarchy does not undergo major changes in the tran-
sition from effector phase to memory phase. Weak responses
were consistently detected against GP276, NP235, NP205, and
GP118. Responses against GP92 and the novel epitope NP163
were detectable but close to background levels (Fig. 1).
The subsequent experiments in this study were done with
the A22.2b strain of LCMV. This virus differs from the
Armstrong strain in that it readily establishes chronic infec-
tions, with infected mice being viremic for up to one month
(Puglielli et al., 2001). This allowed us to compare CD8
T-cell responses during the early and late phases of chronic
infection.
To modulate the number of viral epitopes, we have used
three approaches. First, antiviral responses were analyzed in
H-2Db and H-2Kb knockout mice (Pe´rarnau et al., 1999).
Removing either MHC class I molecule effectively elimi-
nates a large fraction of the pool of epitopes (Table 2).
Second, we used a variant LCMV strain that carries a
mutation in the GP33 epitope (Puglielli et al., 2001). Fi-
nally, responses were studied during the acute response (at
8 days post infection) and after persistent infection (day 68
pi) during which the NP396-specific T cells are expected to
be eliminated (Zajac et al., 1998; Fuller and Zajac, 2003;
Wherry et al., 2003). By combining these “epitope loss”
strategies with a large set of epitopes, we could create a
wide variety of epitope constellations (Table 2).
Modulation of CD8 T-cell responses during acute
infection
In the first series of experiments, we have investigated
antiviral responses in the absence of either the H-2Db or the
H-2Kb molecules. In/mice, we found responses against
most of the epitopes at 8 days after infection with the
A22.2b strain (Fig. 2). Compared to the epitope hierarchy in
Armstrong-infected mice (Fig. 1), it is striking that in this
early phase of the chronic infection the subdominant
epitopes GP276, NP205, and GP118 were much more dom-
inant (Fig. 2). In addition, the total magnitude of the re-
sponse was reduced in A22.2b-infected mice, compared to
Fig. 2. Impact of MHC class I loss on the hierarchy of antiviral responses.
C57BL/6/ mice (upper panel) and H-2Db (middle panel) and H-2Kb
knockout mice (lower panel) were infected with LCMV A22.2b and
splenocytes were harvested at 8 days postinfection. Peptide-stimulated
splenocytes were stained for CD8 and IFN-. Percentages of CD8/
IFN- of total CD8 T cells are shown (results from three individual mice).
Stimulation with GP33 reveals both GP33/Db and GP34/Kb responses.
Table 1
Sequences and binding affinities of H-2b epitopesa
Peptide Sequence Restriction Binding (IC50, nM) Reference
NP396-404 FQPQNGQFI Db 4.4 Van der Most et al., 1996
GP276-286 SGVENPGGYCL Db 52 Van der Most et al,. 1996
GP33-43 KAVYNFATCGI Db 395 Van der Most et al., 1996; Puglielli et al., 2001
GP92-101 CSANNSHHYI Db 470 Van der Most et al., 1996
NP163-177 KDSSLLNNQFGTMPSb Db 6333c This paper; Van der Most et al., 1996
GP34-43 AVYNFATCGI Kb 22 Puglielli et al., 2001
GP118-125 ISHNFCNL Kb 371 Van der Most et al., 1996
NP205-212 YTVKYPNL Kb 170 Van der Most et al., 1996
NP235-249 INISGYNFSLGAAVKb Kb 10,000c This paper, Van der Most et al., 1996
a Peptide binding was expressed as the IC50 (nM) (Van der Most et al., 1996).
b Potential H-2Db- and H-2Kb-motif fitting peptides are indicated in bold.
c IC50 values based on predicted epitopes SLLNNQFGTM for NP163 and ISGYNFSL for NP235. IC50 values5000 indicate lack of binding, suggesting
that the epitopes tested may not be the actual minimal epitopes.
95R.G. van der Most et al. / Virology 315 (2003) 93–102
the Armstrong infection (Fig. 2). Removal of the H-2Db-
restricted response (which includes the dominant NP396
and GP33 epitopes) made the hierarchy shift even more
evident: GP34, NP205, NP235, and GP118 were essentially
codominant (Fig. 2). The NP396-specific response was still
dominant in H-2Kb knockout mice: the lack of competition
from the subdominant H-2Kb-restricted epitopes NP205 and
GP118 clearly has a beneficial effect on the NP396-specific
response in chronic infection (Fig. 2). Thus, the eventual
demise of the NP396-specific response (Zajac et al., 1998;
Wherry et al., 2003) is already evident at this early phase of
infection with the A22.2b virus: NP396-specific CD8 T
cells are less competitive when NP205- and GP118-specific
T cells are also present (in/ mice). In addition, the level
of IFN- produced by NP396-specific cells was decreased
compared to the Armstrong infection (see below).
We have recently described an LCMV CD8 T-cell
epitope escape variant (Puglielli et al., 2001). This L1 vari-
ant virus is derived from the A22.2b strain and carries a
single amino acid substitution in the GP33 epitope, yielding
the sequence KAAYNFATCGI. This V-to-A mutation at
position 35 of the glycoprotein destroys the H-2Db-re-
stricted GP33-43 epitope, but not the overlapping H-2Kb-
restricted GP34-42 epitope (Puglielli et al., 2001). Thus, by
using the L1 variant virus, we were able to remove one
dominant epitope from the total response. Responses
were first analyzed at 8 days postinfection in / mice
and H-2Db or H-2Kb knockout mice. In L1-infected /
mice, we found that the epitope hierarchy was very sim-
ilar to the hierarchy in A22.2b-infected / mice, with
the exception of the GP33/34 response, which was re-
duced (Fig. 3a). As expected, staining with GP33- and
GP34-loaded MHC class I tetramers showed that the
H-2Db-restricted GP33 response was selectively lost
(Fig. 3b). In H-2Db knockout mice infected with the L1
virus, antiviral T-cell responses were predominantly di-
rected against NP205 and GP118 (Fig. 3a). Interestingly,
H-2Kb-restricted GP34-specific responses were less dom-
inant in L1-infected H-2Db knockout mice than in
A22.2b-infected H-2Db knockout mice. This suggests
that the V-to-A mutation also affects the H-2Kb epitope:
GP34-specific T cells in L1-infected mice are less “com-
petitive” than in A22.2b-infected mice. The response in
H-2Kb knockout mice was heavily dominated by NP396-
specific T cells, similar to the response against A22.2b
virus in H-2Kb knockout mice. It is striking that H-2Kb
knockout mice displayed the strongest response by far (in
terms of frequencies of LCMV-specific cells), both the
A22.2b virus and the L1 escape variant. This can be
completely attributed to the NP396 response.
Changes in the epitope hierarchy during chronic infection
Chronic viral infection can have profound effects on
epitope-specific T-cell responses. In the case of LCMV, it
has been demonstrated that responses against the dominant
NP396 epitope disappear during chronic infection: NP396-
specific CD8 T cells are deleted (Zajac et al., 1998). We
asked what the impact of this phenomenon would be on the
epitope hierarchy and whether the breadth of the response
would change as a result of chronic antigenic stimulation.
For these experiments we infected / mice, as well as
H-2Kb and H-2Db deficient mice with either the parental
A22.2b virus or the L1 variant, and analyzed responses after
long-term (60 days) viral infection. We anticipated that,
during chronic infection, the NP396-specific response
would be lost in these mice. A summary of the expected
configurations is provided in Table 2.
In the basic experimental setup, i.e., infection of /
mice with A22.2b, we indeed noticed a complete absence of
NP396-specific responses, confirming earlier data (Zajac et
al., 1998; Fuller and Zajac, 2003; Wherry et al., 2003) (Fig.
4). Strikingly however, NP205- and NP235-specific re-
sponses were also dramatically reduced compared to the
Day 8 response (compare Figs. 2 and 4). The antiviral
Table 2
Number of expected epitopes in each experimental setting
Mice LCMV strain Days p.i. Epitope
NP396 GP33 GP276 GP91 NP163 GP34 GP118 NP205 NP235
/ A22.2b 8 xa x x x x x x x x
H-2Kb/ A22.2b 8 x x x x x
H-2Db/ A22.2b 8 x x x x
/ L1 variant 8 x x x x x x x x
H-2Kb/ L1 variant 8 x x x x
H-2Db/ L1 variant 8 x x x x
/ A22.2b 68 x x x ?b x x ? ?
H-2Kb/ A22.2b 68 x x x ?
H2-Db/ A22.2b 68 x x ? ?
/ L1 variant 68 x x ? x x ? ?
H-2Kb/ L1 variant 68 x x ?
H-2Db/ L1 variant 68 x x ? ?
a Epitope expected to take part in the response
b Fate of T cells specific for epitope unknown based on previous literature (Zajac et al., 1998).
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response after chronic A22.2b infection was dominated by
the GP33, GP276, and GP118 epitopes. Removal of the
H-2Db-restricted epitopes in the H-2Db knockout mice
(GP276 and GP33) resulted in an antiviral response domi-
nated by just two epitopes, GP34 and GP118. In fact, ex-
tremely high responses (close to 20% of all CD8 T cells,
Fig. 4) were detected against the GP118 epitope, demon-
strating that this epitope evolved from subdominance to
near absolute immunodominance. In the reverse situation, in
the H-2Kb knockout mice, responses against GP33 and
GP276 were dominant. These experiments underscore the
dominant role of GP-derived epitopes during chronic infec-
tion. The changed hierarchy after chronic infection is clearly
illustrated in Fig. 5: at 8 days after infection with A22.2b,
the hierarchy still bears some similarity to the hierarchy in
Armstrong-virus infected mice. (Murali-Krishna et al.,
1988), but at Day 68 the hierarchy in persistently infected
mice is very different. Note that even at Day 8 after A22.2b
infection, the responses against the dominant epitopes
NP396 and GP33 were less dominant, and that the impact of
chronic infection on the NP396 response was already evi-
dent by the reduced levels of IFN- produced by these cells.
Clearly, the CD8 T cells recognizing subdominant epitopes
from the glycoprotein (GP276 and GP118) are the best
survivors in the face of persistent antigenic stimulation.
We then further narrowed down the breadth of the po-
tential response by using the L1 variant virus in the chronic
infection setting, thereby removing one of the key epitopes
Fig. 3. Impact of epitope loss on the hierarchy of antiviral responses. (a) C57BL/6/ mice (upper panel) and H-2Db (middle panel) and H-2Kb knockout
mice (lower panel) were infected with the LCMV A22.2b L1 variant. Splenocytes were harvested at 8 days postinfection. Peptide-stimulated splenocytes were
stained for CD8 and IFN-. Percentages of CD8/IFN- of total CD8 T cells are shown (results from three individual mice). Stimulation with GP33 reveals
both GP33/Db and GP34/Kb responses. (b) MHC class I tetramer staining of GP33/Db and GP34/Kb responses in acutely A22.2b-infected C57BL/6/ mice
(upper panel) and H-2Db (middle panel) and H-2Kb (lower panel) knockout mice. Percentages of tetramer-positive CD8 T cells of total CD8 T cells are shown.
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from the response (Fig. 4). Analysis of the antiviral re-
sponse in L1-infected / mice at 68 days pi indeed
identified GP276 and GP118 as the dominant epitopes.
After removing the GP276 epitope from the response in the
H-2Db knockout mice, the GP118 response became immu-
nodominant and GP34 was the sole subdominant epitope. In
chronically infected H-2Kb knockout mice, the response
was dominated by GP276 and two very “weak” epitopes,
GP92 and NP165.
Staining with MHC class I tetramers for NP396, GP33,
GP34, GP276, and NP205 confirmed these results (Fig. 6),
and also revealed that the majority of antiviral CD8 T cells
present at Day 68 pi (in each epitope constellation) were
L-selectinlow, suggesting an activated phenotype (data not
shown). Discrepancies between numbers of tetramer-posi-
tive CD8 T cells and IFN--producing T cells, indicative of
the presence of functionally inactivated cells (Zajac et al.,
1998), were observed for all GP epitopes analyzed (GP33,
GP34, and GP276) (data not shown). In particular, it should
be noted that GP34-specific responses were not deleted
during chronic infection with either A22.2b or the L1 virus
(see Discussion).
Fig. 4. Effect of chronic viral infection on epitope hierarchy: NP-specific responses are selectively lost. C57BL/6/ mice (upper panels) and H-2Db (middle
panels) and H-2Kb knockout mice (lower panels) were infected with LCMV A22.2b (left panels) or the L1 variant (right panels), as indicated. Splenocytes
were harvested at 8 days postinfection. Peptide-stimulated splenocytes were stained for CD8 and IFN-. Percentages of CD8/IFN- of total CD8 T cells
are shown (results from three individual mice). Stimulation with GP33 reveals both GP33/Db and GP34/Kb responses.
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Discussion
By analyzing immunodominance under a variety of ex-
perimental conditions, we have shown that the epitope hi-
erarchy is extremely flexible. For instance, even exceed-
ingly weak epitopes such as GP91 and NP163 can rise to
codominance under the right conditions. However, a major
hierarchy change requires the loss of multiple epitopes. Loss
of a single epitope in the L1 variant virus has very little
impact on the epitope hierarchy and on the total response,
whereas the hierarchy does change in the H-2Db and H-2Kb
knockout mice. Compensatory responses are readily de-
tected when most of the dominant epitopes are not recog-
nized. Subdominant epitopes play a major role in these
compensatory responses, illustrated by the strong NP205-
and GP276-specific responses in A22.2b-infected H-2Db
knockout, and L1-infected H-2Kb knockout mice, respec-
tively. Our data are consistent with the recently postulated
role of IFN- in establishing immunodominance hierarchies
(Rodrigues et al., 2002): IFN- produced by the dominant
Fig. 5. Direct comparison of the hierarchy in / mice acutely infected with LCMV ARM (upper panels) or A22.2b (middle panels) (Day 8), or chronically
infected with A22.2b (lower panel) (Day 68). NP-specific responses are selectively lost during chronic infection. Specific cells are identified by IFN-
production following antigenic stimulation. Indicated are the virus used for infection, duration of the infection, and the epitope. Percentages of CD8/IFN-
of total CD8 T cells are shown (data from one representative / mouse).
Fig. 6. Direct comparison of the hierarchy in mice acutely infected with LCMV ARM (upper panels) or A22.2b (middle panels) (Day 8), or chronically
infected with A22.2b (lower panel) (Day 68). Specific cells are identified by MHC class I tetramer staining. Indicated are the virus used for infection, duration
of the infection, and the epitope. Splenocytes were stained as with anti-CD8 antibodies and with MHC class I tetramers. Percentages of tetramer-positive CD8
T cells of total CD8 T cells are shown (data from one representative / mouse).
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CD8 T cells has a suppressive effect on other cells. Thus,
the absence of dominant responses removes a major local
source of IFN-, thereby allowing increased proliferation of
CD8 T-cell precursors that recognize subdominant epitopes.
Perhaps the most intriguing result of our studies is the
complete hierarchy reversal in chronically infected mice. In
the most extreme situation, i.e., H-2Db knockout mice
chronically infected with the L1 variant virus, we found a
dominant response against a single subdominant GP
epitope, GP-118. Our data extend previous work from our
laboratory (Wherry et al., 2003) and provide an important
clue toward the underlying mechanism: chronic infection
conditions favor responses against the GP epitopes at the
expense of all dominant and subdominant NP epitopes. This
“NP versus GP rule” extends to most epitopes: even dom-
inant GP epitopes (GP33, GP34) fare better than subdomi-
nant NP epitopes (NP205, NP235). One partial exception
was the deletion of GP34-specific responses in mice chron-
ically infected with the clone 13 strain of LCMV (Wherry et
al., 2003). The most likely explanation for this discrepancy
is that the clone 13 virus differs from the A22.2b virus in
terms of persistence and viral loads: clone 13 viremia usu-
ally lasts longer (Wherry et al., 2003) (see below). Similar
results were obtained in BALB/c mice, in which the re-
sponse shifts from the dominant NP118 epitope toward the
subdominant GP283 and GP99 epitopes during chronic in-
fection (van der Most et al., 1996; unpublished results). In
addition, this phenomenon of hierarchy shift from a viral
nucleoprotein toward an envelope protein has been ob-
served in mice persistently infected of with mouse hepatitis
virus (Bergmann et al., 1999).
To explain the different fates of NP and GP specific T
cells, we assume that the loss of NP responses results from
exhaustion and deletion of the cognate T cells (Zajac et al.,
1998; Fuller and Zajac, 2003; Wherry et al., 2003; Zhou et
al., 2002). It seems likely that overexposure-induced inac-
tivation (Wherry et al., 2002) operates differentially in NP-
and GP-specific responses. There are three obvious differ-
ences between GP and NP: (i) quantity, (ii) routing of
biosynthesis and antigen processing, and (iii) timing of
production. We propose that neither quantity nor the routing
of biosynthesis and processing can entirely explain the dif-
ferent fates of GP- and NP-specific T cells. First, although
NP is indeed produced in higher quantities than GP (Wherry
et al., 2003; Buchmeier and Zajac, 1999), it was observed
the GP33 epitope is presented in higher copy numbers on
the surface of LCMV-infected cells than the NP396 epitope
(Gallimore et al., 1998a). It is also difficult to imagine that
subdominant epitopes such as NP205 and NP235 are pre-
sented in extremely high doses. Second, the correlation
between protein origin and T-cell fate could suggest a role
of the different biosynthesis and processing routes of NP
and GP, with antigen processing of GP depending on ret-
rograde transport of defective ribosomal products back into
the cytoplasm (Yewdell, 2002). However, it has been shown
that ER targeting does not impede antigen presentation
(Golovina et al., 2002), consistent with the high levels of the
GP33 epitope on the surface of infected cells (Gallimore et
al., 1998a). In contrast, differential timing of GP and NP
synthesis could provide part of the answer because GP is
synthesized later than NP (Southern, 1996). The NP mRNA
is transcribed directly from the LCMV genomic RNA,
whereas production of the GP mRNA cannot start until the
viral genomic RNA is replicated (Southern, 1996), a process
in which the newly synthesized NP protein plays a crucial
role (Lee et al., 2000; Pinschewer et al., 2003). Thus, NP
mRNA is detected 9–12 h earlier than GP mRNA (Fuller-
Pace and Southern, 1998). This implies that newly infected
cells will present NP epitopes earlier than GP epitopes.
Consequently, NP-specific T cells are the first to encounter
antigen and will then start producing IFN-. IFN- plays a
key role in shaping epitope hierarchies by suppressing com-
peting responses (Rodrigues et al., 2002), leading to a sit-
uation in which NP-specific T cells can suppress GP-spe-
cific T cells. GP-specific cells would then be protected. In
support of these ideas, there is both experimental and the-
oretical evidence that “recruitment time” is a key factor in
determining dominance and subdominance (de Boer et al.,
2001; Bousso et al., 1999).
This hypothesis also provides a possible explanation for
the different behavior of the GP34-specific responses in
A22.2b- and clone 13-infected mice (Wherry et al., 2003;
this study). Clone 13 infection results in more prolonged
antigen exposure because the virus persists for a longer
period of time. Thus, the GP34-specific response could be
considered “next in line”: once all NP-specific responses are
deleted (as in the A22.2b infection), the strong GP34-
epitope (IC50  22 nM) (Puglielli et al., 2001) is the likely
next candidate to go.
Interestingly, differences between NP and GP expression
may be even more extreme during persistent infection: Old-
stone and Buchmeier described a shutdown of GP expres-
sion in persistently infected mice (Oldstone and Buchmeier,
1982). It is possible that a type-I IFN-induced block of viral
replication causes the preferential synthesis of NP mRNA
(which is transcribed independent of viral replication) com-
pared to the GP mRNA (which depends on replication).
Obviously, restricted GP expression in persistent infection
(Oldstone and Buchmeier, 1982) would stimulate the sur-
vival of GP-specific CD8 T cells. Consistent with this,
Wherry et al. have provided direct evidence that GP-derived
epitopes are presented at dramatically lower levels com-
pared to the dominant NP396 epitope in chronically infected
mice (Wherry et al., 2003).
In conclusion, we have exploited an important aspect of
the LCMV infection model, i.e., the many CD8 T cell
epitopes from both NP and GP, to support the hypothesis
that there is a link between T-cell survival and the epitopes
seen by these cells. The fact that we analyzed a plethora of
epitopes provided the major clue to understanding the un-
derlying mechanism. We propose that the differential kinet-
ics of NP and GP production (Southern, 1996; Fuller-Pace
and Southern, 1988) and the possible restriction of GP
synthesis (Oldstone and Buchmeier, 1982) protect the GP-
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specific CD8 T-cell response. Our data indicate that those T
cells that escaped deletion may play a key role in the
eventual control of a chronic LCMV infection. The ultimate
aim would be to mobilize such “long-term surviving” re-
sponses, thereby creating possibilities for therapeutic vac-
cination.
Materials and methods
Mice and infection protocols
C57BL/6 mice were obtained from Jackson Laboratories
(Bar Harbor, ME). H-2Db and H-2Kb knockout mice (Pe´r-
arnau et al., 1999) were constructed on a B6 background
(Puglielli et al., 2001). For analysis of antiviral T-cell re-
sponses, mice were infected intraperitoneally with 2  105
pfu LCMV Armstrong, or intravenously with 106 pfu of
either LCMV A22.2b or the A22.2b-L1 variant virus
(Puglielli et al., 2001). Spleen cell suspensions were pre-
pared as described (van der Most et al., 1996; Puglielli et al.,
2001). Infectious virus was quantified on Vero cells as
described (van der Most et al., 1996, 1998). Mice infected
with A22.2b virus or the L1 variant were viremic for at least
28 days. No viremia could be detected at day 60 pi. All
animal experiments were approved by the Emory University
Institutional Animal Care and Use Committee (IACUC).
Intracellular cytokine staining
Intracellular IFN- staining was done as described (Mu-
rali-Krishna et al., 1998). Briefly, 106 splenocytes were
cultured with peptide and GolgiPlug (BD PharMingen) for
6 h at 37°C. After this period, cells were stained with
allophycocyanin-conjugated (APC) or PE-conjugated mAbs
against CD8 (clone 53-6.7), followed by intracellular stain-
ing with a FITC-labeled anti-IFN- mAb (XMG1.2) using
the Cytofix/Cytoperm kit, as described by the manufacturer
(BD PharMingen). Novel epitopes (NP163–177 and
NP235–249) were identified using a set of overlapping
15-mer peptides spanning the viral nucleoprotein and gly-
coprotein (5-amino acid overlap). The overlapping peptide
library was synthesized at Epimmune Corp. (San Diego,
CA). All other peptides were synthesized at the Department
of Microbiology and Immunology at Emory University. All
mAbs were obtained from BD PharMingen (San Diego,
CA). Cells were acquired on a FACScalibur flow cytometer
and analyzed using CellQuest software. Lymphocytes were
gated using forward- and side-scatter parameters.
Tetramer staining
MHC class I tetramers specific for the NP396 (Db), GP33
(Db), GP34 (Kb), NP205 (Kb), and GP276 (Db) epitopes
were made as described (Altman et al., 1996; Murali-
Krishna et al., 1998). Tetramer staining, using APC-labeled
tetramers, PE-labeled anti-CD8, and FITC-labeled anti-
CD62L (MEL-14), or anti-CD44 was performed at 4°C.
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